These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14701785)

  • 1. Doctor, does this mean I'm going to starve to death?
    Whitworth MK; Whitfield A; Holm S; Shaffer J; Makin W; Jayson GC
    J Clin Oncol; 2004 Jan; 22(1):199-201. PubMed ID: 14701785
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of intestinal obstruction in ovarian cancer.
    Krebs HB; Helmkamp F
    Oncology (Williston Park); 1989 May; 3(5):25-31; discussion 31-2, 35-6. PubMed ID: 2577883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients.
    Brard L; Weitzen S; Strubel-Lagan SL; Swamy N; Gordinier ME; Moore RG; Granai CO
    Gynecol Oncol; 2006 Oct; 103(1):176-80. PubMed ID: 16564074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of cisplatin multiagent chemotherapy and total parenteral hyperalimentation on bowel obstruction caused by ovarian cancer.
    Tunca JC
    Gynecol Oncol; 1981 Oct; 12(2 Pt 1):219-21. PubMed ID: 6795096
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diary of a woman physician suffering from cancer. 12. Struggle with intestinal obstruction].
    Osakabe Y
    Kangogaku Zasshi; 1986 Dec; 50(12):1404-7. PubMed ID: 3099040
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidence of intestinal obstruction following intraperitoneal chemotherapy for ovarian tubal and peritoneal malignancies.
    Kehoe SM; Williams NL; Yakubu R; Levine DA; Chi DS; Sabbatini PJ; Aghajanian CA; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2009 May; 113(2):228-32. PubMed ID: 19254808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of quality of life of patients submitted to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis of gastrointestinal and ovarian origin and identification of factors influencing outcome.
    Macrì A; Maugeri I; Trimarchi G; Caminiti R; Saffioti MC; Incardona S; Sinardi A; Irato S; Altavilla G; Adamo V; Versaci A; Famulari C
    In Vivo; 2009; 23(1):147-50. PubMed ID: 19368140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A technique for managing terminally ill ovarian carcinoma patients.
    Chapman C; Bosscher J; Remmenga S; Park R; Barnhill D
    Gynecol Oncol; 1991 Apr; 41(1):88-91. PubMed ID: 1902811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma.
    Pothuri B; Montemarano M; Gerardi M; Shike M; Ben-Porat L; Sabbatini P; Barakat RR
    Gynecol Oncol; 2005 Feb; 96(2):330-4. PubMed ID: 15661217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer of the ovary.
    Matulonis U; Abrahm JL
    N Engl J Med; 2005 Mar; 352(12):1268-9; author reply 1268-9. PubMed ID: 15788509
    [No Abstract]   [Full Text] [Related]  

  • 11. Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: a Gynecologic Oncology Group Study.
    Wenzel LB; Huang HQ; Armstrong DK; Walker JL; Cella D;
    J Clin Oncol; 2007 Feb; 25(4):437-43. PubMed ID: 17264340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Straight talk about ovarian cancer.
    Martin VR
    Nursing; 2005 Apr; 35(4):36-41; quiz 42. PubMed ID: 15818250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life evaluations in patients with ovarian cancer during chemotherapy treatment.
    Le T; Leis A; Pahwa P; Wright K; Ali K; Reeder B; Hopkins L; Fung MF
    Gynecol Oncol; 2004 Mar; 92(3):839-44. PubMed ID: 14984950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life of Chinese patients with ovarian malignancies during chemotherapy under condition of no recurrence.
    Ding Y; Zhu YL; Zhang MF
    Cancer Nurs; 2007; 30(3):243-51. PubMed ID: 17510589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chylothorax in a patient with ovarian tumour.
    Gupta PR; Taly A; Joshi N; Gupta S; Meena RC; Jain S
    Indian J Chest Dis Allied Sci; 2005; 47(1):43-6. PubMed ID: 15704715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal obstruction in advanced ovarian cancer: what does the patient want?
    Rubin SC
    Gynecol Oncol; 1999 Dec; 75(3):311-2. PubMed ID: 10600281
    [No Abstract]   [Full Text] [Related]  

  • 17. Ovarian cancer.
    Fitch MI; Turner F
    Can Nurse; 2006 Jan; 102(1):16-20. PubMed ID: 16468226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the management of women with ovarian cancer.
    Eltabbakh GH
    Minerva Ginecol; 2004 Feb; 56(1):81-9. PubMed ID: 14973412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival after ovarian cancer induced intestinal obstruction.
    Piver MS; Barlow JJ; Lele SB; Frank A
    Gynecol Oncol; 1982 Feb; 13(1):44-9. PubMed ID: 7060992
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-acting octreotide for the treatment and symptomatic relief of bowel obstruction in advanced ovarian cancer.
    Matulonis UA; Seiden MV; Roche M; Krasner C; Fuller AF; Atkinson T; Kornblith A; Penson R
    J Pain Symptom Manage; 2005 Dec; 30(6):563-9. PubMed ID: 16376743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.